Samyang Biopharmaceuticals competitive analysis

Latest publications and patents of Samyang Biopharmaceuticals New

Explore the latest publications and patents granted to Samyang Biopharmaceuticals, showcasing their recent innovations and technological advancements.

Last updated on: Sep 23, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Samyang Biopharmaceuticals

Nov 1, 2017Percutaneously Absorbable Preparation Containing Fentanyl And A Homologue ThereofRevoked

Explore Samyang Biopharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 25, 2025
Patent NumberGrant DateTitleTotal Oppositions
Nov 1, 2017Percutaneously Absorbable Preparation Containing Fentanyl And A Homologue Thereof1

Latest PTAB cases involving Samyang Biopharmaceuticals

Discover the latest PTAB cases involving Samyang Biopharmaceuticals, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Samyang Biopharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 25, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
SAMYANG BIOPHARMACEUTICALS - 1 - - Non-Active
HEXAL563 - - Highly Aggressive